Moa Pontén
Postdoktorala Studier
E-postadress: moa.ponten@ki.se
Telefon: +46852486908
Besöksadress: Norra Stationsgatan 69, plan 7, 11364 Stockholm
Postadress: K8 Klinisk neurovetenskap, K8 CPF Bjureberg, 171 77 Stockholm
Del av:
- Institutionen för klinisk neurovetenskap
- Centrum för psykiatriforskning vid CNS
- ESSI – Emotionsreglering, Självskadebeteende, Suicid och Intervention – Johan Bjurebergs forskargrupp
Artiklar
- Journal article: PSYCHIATRY RESEARCH. 2025;351:116638Ponten M; Lee M; Khoo S; Nilsson G; Nevin E; Wallden Y; Ougrin D; Cummins TM; Flygare O; Bjureberg J
- Article: BMC PSYCHIATRY. 2024;24(1):904Ponten M; Flygare O; Bellander M; Karemyr M; Nilbrink J; Hellner C; Ojala O; Bjureberg J
- Article: PSYCHOLOGICAL MEDICINE. 2024;54(6):1207-1214Ponten M; Jonsjo M; Vadenmark V; Moberg E; Grannas D; Andersson G; Boersma K; Hedman-Lagerlof E; Kleinstaeuber M; Weise C; Kaldo V; Ljotsson B; Andersson E; Axelsson E; Jensen K
- Article: BMJ OPEN. 2023;13(3):e066987Hansson KS; Lindqvist G; Stening K; Fohlman J; Wojanowski A; Ponten M; Jensen K; Gerdle B; Elmqvist C
- Article: SCIENTIFIC REPORTS. 2022;12(1):17704Klosowska J; Bajcar EA; Bieniek H; Braczyk J; Joshanloo M; Mattarozzi K; Bagnis A; Ponten M; Lalouni M; Geers AL; Clemens KS; Park J; Choi G; Choi Y-K; Jung W; Son E; Yoon HY; Babel P
- Article: JOURNAL OF HEALTH PSYCHOLOGY. 2022;27(1):135-146Blease CR; Delbanco T; Torous J; Ponten M; DesRoches CM; Hagglund M; Walker J; Kirsch I
- Article: JOURNAL OF ALZHEIMERS DISEASE. 2021;84(4):1821-1832Matthiesen ST; Rosenkjaer S; Ponten M; Jensen KB; Gottrup H; Vase L
- Article: MOLECULAR PAIN. 2020;16:1744806920927625Ponten M; Fust J; Kosek E; Guterstam J; Jensen K
- Journal article: 2019Pontén M; Fust J; D'Onofrio P; van Dorp R; Sunnergård L; Ingre M; Axelsson J; Jensen K
- Article: SCIENTIFIC REPORTS. 2019;9(1):12478Ponten M; Fust J; D'Onofrio P; van Dorp R; Sunnergard L; Ingre M; Axelsson J; Jensen K
- Article: PAIN REPORTS. 2019;4(3):e698Ponten M; Ljotsson B; Jensen K
- Article: NEUROLOGY. 2017;88(20):1912-1918Jensen KB; Kirsch I; Ponten M; Rosen A; Yang K; Gollub RL; des Portes V; Kaptchuk TJ; Curie A
Alla övriga publikationer
- Preprint: PSYARXIV. 2024Ponten M; Flygare O; Bellander M; Karemyr M; Nilbrink J; Hellner C; Ojala O; Bjureberg J
- Preprint: PSYARXIV. 2023Flygare O; Ojala O; Ponten M; Klintwall L; Karemyr M; Sjöblom K; Wallert J; Hellner C; Nilbrink J; Bellander M; Bjureberg J
- Review: JAMA NETWORK OPEN. 2022;5(11):e2243848Gedin F; Blome S; Ponten M; Lalouni M; Fust J; Raquette A; Lundquist VV; Thompson WH; Jensen K
- Preprint: PSYARXIV. 2022Kłosowska J; Bajcar EA; Bieniek H; Brączyk J; Joshanloo M; Mattarozzi K; Bagnis A; Ponten M; Lalouni M; Geers A; Clemens KS; Park J; Choi G; Choi Y-K; Jung W; Son E; Yoon HY; Babel P
- Review: JAMA NETWORK OPEN. 2020;3(3):e201423Stridh A; Ponten M; Arver S; Kirsch I; Abe C; Jensen KB
- Other: LAKARTIDNINGEN. 2018;115:EZSAJensen K; Pontén M
Forskningsbidrag
- Swedish Research Council1 December 2023 - 30 November 2026Suicide is the leading cause of death for ages 10-19 years in Sweden. The most reliable predictor of suicide is self-harm (including suicide attempts). Decades of research have failed to produce reliable assessments of risk factors for self-harm that could be applied with confidence in the clinic. Further, few evidence-based out-patient treatments for self-harm exist to date. Instead, involuntary care is increasingly used in this population, despite evidence indicating that it may worsen prognosis. Two studies will be conducted. Study 1 aims to identify clinically applicable risk factors of self-harm and Study 2 is a randomized clinical trial for youth who self-harm. Study 1 will for the first time assess youth at risk of self-harm prospectively (aged 12 to 14 years) at two timepoints: pre onset of self-harm and at follow-up. Participants will be assessed using a range of psychophysiological, cognitive, and psychosocial measures, with a particular focus on pain-sensitivity. Identified individuals with self-harm will be included in a parallel randomized controlled trial (total N=200) of a cognitive behavioral family treatment targeting risk factors for self-harm and suicide, compared to an active control group. By identifying clinically applicable risk factors and evaluating a potentially effective out-patient intervention, this project aims to reduce the need for involuntary care and prevent suicide in youth.
Anställningar
- Postdoktorala Studier, Klinisk neurovetenskap, Karolinska Institutet, 2025-2028
Examina och utbildning
- Medicine Doktorsexamen, Institutionen för klinisk neurovetenskap, Karolinska Institutet, 2023
- Psykologexamen, Karolinska Institutet, 2018